The generic drug industry has become essential to developing countries that need access to cheaper drugs to treat their heavy burdens of communicable diseases.
Rigor académico, oficio periodístico
Artículos sobre Generic drugs
Mostrando 21 - 21 de 21 artículo
Principales colaboradores
-
Reader in Intellectual Property Law, City, University of London
-
Research Fellow, Stellenbosch University
-
Associate Professor of Law, Washington University in St. Louis
-
Lecturer in Accounting & Management, Lancaster University
-
Joel Lexchin es Amigo de The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Professor and Director, Centre for African Studies, University of Mumbai, University of Mumbai
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor of Health Law and Bioethics, Case Western Reserve University
-
Professor, Abell Chair in Synthetic Biology, Colorado State University
-
Postdoctoral Researcher in Chemical and Biological Engineering, Colorado State University
-
Professor of political science, Director of the Oslo SDG Initiative, Host of "In Pursuit of Development" podcast, University of Oslo
-
Professor of Law, Georgia State University
-
Professor of Industrial and Operations Engineering, University of Michigan
-
Ph.D. Candidate in Industrial and Operations Engineering, Clemson University
-
Postdoctoral Fellow in Quality of Medical Products, University of California, San Francisco
